Search Results

There are 107873 results for: content related to: Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?

  1. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro

    Journal of Biomedical Materials Research Part A

    Volume 89A, Issue 1, 1 April 2009, Pages: 46–56, C. Faucheux, E. Verron, A. Soueidan, S. Josse, M. D. Arshad, P. Janvier, P. Pilet, J. M. Bouler, B. Bujoli and J. Guicheux

    Version of Record online : 10 APR 2008, DOI: 10.1002/jbm.a.31989

  2. You have full text access to this OnlineOpen article
    Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma

    Journal of Veterinary Internal Medicine

    Volume 30, Issue 4, July/August 2016, Pages: 1187–1196, M.L. Byrum, H.C. Pondenis, R.L. Fredrickson, K.L. Wycislo and T.M. Fan

    Version of Record online : 2 JUN 2016, DOI: 10.1111/jvim.14257

  3. You have free access to this content
    Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways

    Journal of Thrombosis and Haemostasis

    Volume 5, Issue 1, January 2007, Pages: 166–173, M. HASMIM, G. BIELER and C. RÜEGG

    Version of Record online : 13 OCT 2006, DOI: 10.1111/j.1538-7836.2006.02259.x

  4. Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats

    Journal of Biomedical Materials Research Part A

    Volume 76A, Issue 1, January 2006, Pages: 133–143, Bastian Peter, Olivier Gauthier, Samia Laïb, Bruno Bujoli, Jérôme Guicheux, Pascal Janvier, G. Harry van Lenthe, Ralph Müller, Pierre-Yves Zambelli, Jean-Michel Bouler and Dominique P. Pioletti

    Version of Record online : 27 OCT 2005, DOI: 10.1002/jbm.a.30456

  5. You have free access to this content
    Zoledronate and pamidronate depress neutrophil functions and survival in mice

    British Journal of Pharmacology

    Volume 165, Issue 2, January 2012, Pages: 532–539, JWP Kuiper, C Forster, C Sun, S Peel and M Glogauer

    Version of Record online : 16 DEC 2011, DOI: 10.1111/j.1476-5381.2011.01592.x

  6. Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)

    Clinical Endocrinology

    Volume 70, Issue 6, June 2009, Pages: 838–846, Ian Chapman, Hugh Greville, Peter R. Ebeling, Susannah J. King, Tom Kotsimbos, Patricia Nugent, Rosie Player, Duncan J. Topliss, Janet Warner and John W. Wilson

    Version of Record online : 24 SEP 2008, DOI: 10.1111/j.1365-2265.2008.03434.x

  7. You have free access to this content
    Bisphosphonates in multiple myeloma: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Rahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, Otavio Augusto Camara Clark, Branko Miladinovic, Axel Glasmacher, Ambuj Kumar and Benjamin Djulbegovic

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD003188.pub3

  8. You have full text access to this Open Access content
    In Vivo and In Vitro Efficacy of Zoledronate for Treating Oral Squamous Cell Carcinoma in Cats

    Journal of Veterinary Internal Medicine

    Volume 22, Issue 1, January–February 2008, Pages: 158–163, J.M. Wypij, T.M. Fan, R.L. Fredrickson, A.M. Barger, L.P. De Lorimier and S.C. Charney

    Version of Record online : 14 FEB 2008, DOI: 10.1111/j.1939-1676.2007.0010.x

  9. Early, Middle, or Late Administration of Zoledronate Alleviates Spontaneous Nociceptive Behavior and Restores Functional Outcomes in a Mouse Model of CFA-Induced Arthritis

    Drug Development Research

    Volume 75, Issue 7, November 2014, Pages: 438–448, Carlos Eduardo Morado-Urbina, Perla Abigail Alvarado-Vázquez, Rosa Mariana Montiel-Ruiz, Rosa Issel Acosta-González, Gabriela Castañeda-Corral and Juan Miguel Jiménez-Andrade

    Version of Record online : 9 JUL 2014, DOI: 10.1002/ddr.21183

  10. You have full text access to this Open Access content
    The Bone Biologic Effects of Zoledronate in Healthy Dogs and Dogs with Malignant Osteolysis

    Journal of Veterinary Internal Medicine

    Volume 22, Issue 2, March–April 2008, Pages: 380–387, T.M. Fan, L.P. De Lorimier, L.D. Garrett and H.I. Lacoste

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1939-1676.2008.0046.x

  11. You have full text access to this OnlineOpen article
    Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer

    Cancer Medicine

    Volume 3, Issue 2, April 2014, Pages: 362–375, Ikuo Wada, Hirokazu Matsushita, Shuichi Noji, Kazuhiko Mori, Hiroharu Yamashita, Sachiyo Nomura, Nobuyuki Shimizu, Yasuyuki Seto and Kazuhiro Kakimi

    Version of Record online : 7 FEB 2014, DOI: 10.1002/cam4.196

  12. You have free access to this content
    Duration of Antiresorptive Effects of Low-Dose Zoledronate in Osteopenic Postmenopausal Women: A Randomized, Placebo-Controlled Trial

    Journal of Bone and Mineral Research

    Volume 29, Issue 1, January 2014, Pages: 166–172, Andrew Grey, Mark Bolland, Bobby Mihov, Sumwai Wong, Anne Horne, Greg Gamble and Ian R Reid

    Version of Record online : 19 DEC 2013, DOI: 10.1002/jbmr.2009

  13. Bisphosphonates

    Annals of the New York Academy of Sciences

    Volume 1117, Issue 1, November 2007, Pages: 209–257, R. GRAHAM G. RUSSELL, ZHIDAO XIA, JAMES E. DUNFORD, UDO OPPERMANN, AARON KWAASI, PHILIPPA A. HULLEY, KATHRYN L. KAVANAGH, JAMES T. TRIFFITT, MARK W. LUNDY, ROGER J. PHIPPS, BOBBY L. BARNETT, FRASER P. COXON, MICHAEL J. ROGERS, NELSON B. WATTS and FRANK H. EBETINO

    Version of Record online : 28 NOV 2007, DOI: 10.1196/annals.1402.089

  14. In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation

    Journal of Tissue Engineering and Regenerative Medicine

    Ulrike Kettenberger, Vera Luginbuehl, Philip Procter and Dominique P. Pioletti

    Version of Record online : 9 NOV 2015, DOI: 10.1002/term.2094

  15. You have free access to this content
    Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells

    Veterinary and Comparative Oncology

    Volume 10, Issue 1, March 2012, Pages: 44–56, S. D. Hafeman, D. Varland and S. W. Dow

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1476-5829.2011.00274.x

  16. You have free access to this content
    Comparison of Different Intravenous Bisphosphonate Regimens for Paget's Disease of Bone

    Journal of Bone and Mineral Research

    Volume 22, Issue 10, October 2007, Pages: 1510–1517, Daniela Merlotti, Luigi Gennari, Giuseppe Martini, Fabrizio Valleggi, Vincenzo De Paola, Annalisa Avanzati and Ranuccio Nuti

    Version of Record online : 2 JUL 2007, DOI: 10.1359/jbmr.070704

  17. Inhibition of osteoblast function in vitro by aminobisphosphonates

    Journal of Cellular Biochemistry

    Volume 106, Issue 1, 1 January 2009, Pages: 109–118, Isabel R. Orriss, Michelle L. Key, Kay W. Colston and Timothy R. Arnett

    Version of Record online : 11 NOV 2008, DOI: 10.1002/jcb.21983

  18. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis

    Journal of Clinical Pharmacy and Therapeutics

    Volume 41, Issue 5, October 2016, Pages: 519–523, W. Tan, J. Sun, L. Zhou, Y. Li and X. Wu

    Version of Record online : 21 JUL 2016, DOI: 10.1111/jcpt.12429

  19. You have free access to this content
    Local delivery of zoledronate from a poly (D,L-lactide)—Coating increases fixation of press-fit implants

    Journal of Orthopaedic Research

    Volume 34, Issue 1, January 2016, Pages: 65–71, Thomas Jakobsen, Joan E. Bechtold, Kjeld Søballe, Thomas Jensen, Stefan Greiner, Marianne T. Vestermark and Jørgen Baas

    Version of Record online : 31 JUL 2015, DOI: 10.1002/jor.22979

  20. You have free access to this content
    Zoledronate Is a Potent Inhibitor of Myeloma Cell Growth and Secretion of IL-6 and MMP-1 by the Tumoral Environment

    Journal of Bone and Mineral Research

    Volume 14, Issue 12, December 1999, Pages: 2048–2056, Sophie Derenne, Martine Amiot, Sophie Barillé, Madeleine Collette, Nelly Robillard, Patrice Berthaud, Jean-LUC Harousseau and Régis Bataille

    Version of Record online : 1 DEC 1999, DOI: 10.1359/jbmr.1999.14.12.2048